Osteoporosis Drug May Slow Joint Destruction In Knee Osteoarthritis

Risedronate brand name Actonel, one of the bisphosphonate drugs typically used in the prevention and treatment of osteoporosis, may slow joint destruction and delay the need for joint replacement surgery in patients with knee osteoarthritis (when taken in higher doses), according to research presented at the ACR Annual Scientific Meeting. Study shows Risedronate (Actonel) May Slow Joint Destruction In Knee Osteoarthritis.

Related Resources:

• Guide to Osteoarthritis
• Osteoporosis Drug Options
• Step-by-Step: The Cause of Knee Pain
• Osteoporosis Vs. Osteoarthritis: Similar Names, Different Conditions